Welcome to LookChem.com Sign In|Join Free

CAS

  • or

507487-90-3

Post Buying Request

507487-90-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

507487-90-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 507487-90-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,7,4,8 and 7 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 507487-90:
(8*5)+(7*0)+(6*7)+(5*4)+(4*8)+(3*7)+(2*9)+(1*0)=173
173 % 10 = 3
So 507487-90-3 is a valid CAS Registry Number.

507487-90-3Relevant articles and documents

Increasing metabolic stability via the deuterium kinetic isotope effect: An example from a proline-amide-urea aminothiazole series of phosphatidylinositol-3 kinase alpha inhibitors

Fairhurst, Robin A.,Caravatti, Giorgio,Guagnano, Vito,Aichholz, Reiner,Blanz, Joachim,Blasco, Francesca,Wipfli, Peter,Fritsch, Christine,Maira, Sauveur-Michel,Schnell, Christian,Seiler, Frank H.

, p. 4729 - 4734 (2016)

In vitro metabolic identification studies with a PI3K-α inhibitor lead molecule 1 identified a single predominant site of oxidative metabolism to be occurring within a tert.butyl moiety. Modification of the tert.butyl group within the lead molecule 1, to the corresponding d9-tert.butyl analogue 2, led to an increase in both the in vitro and in vivo metabolic stability. This increase in metabolic stability resulted in a 2-fold increase in the oral bioavailability measured in the rat, and a 3-fold increase in potency in a chronic in vivo study in the mouse, for 2 when compared to 1.

Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation

Furet, Pascal,Guagnano, Vito,Fairhurst, Robin A.,Imbach-Weese, Patricia,Bruce, Ian,Knapp, Mark,Fritsch, Christine,Blasco, Francesca,Blanz, Joachim,Aichholz, Reiner,Hamon, Jacques,Fabbro, Doriano,Caravatti, Giorgio

, p. 3741 - 3748 (2013/07/27)

Phosphatidylinositol-3-kinase α (PI3Kα) is a therapeutic target of high interest in anticancer drug research. On the basis of a binding model rationalizing the high selectivity and potency of a particular series of 2-aminothiazole compounds in inhibiting PI3Kα, a medicinal chemistry program has led to the discovery of the clinical candidate NVP-BYL719.

Discovery of N-Phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors

Wang, Shudong,Midgley, Carol A.,Sca?rou, Frederic,Grabarek, Joanna B.,Griffiths, Gary,Jackson, Wayne,Kontopidis, George,McClue, Steven J.,McInnes, Campbell,Meades, Christopher,Mezna, Mokdad,Plater, Andy,Stuart, Iain,Thomas, Mark P.,Wood, Gavin,Clarke, Rosemary G.,Blake, David G.,Zheleva, Daniella I.,Lane, David P.,Jackson, Robert C.,Glover, David M.,Fischer, Peter M.

scheme or table, p. 4367 - 4378 (2010/09/04)

Through cell-based screening of our kinase-directed compound collection, we discovered that a subset of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amines were potent cytotoxic agents against cancer cell lines, suppressed mitotic histone H3 phosphorylation, and caused aberrant mitotic phenotypes. It was subsequently established that these compounds were in fact potent inhibitors of aurora A and B kinases. It was shown that potency and selectivity of aurora kinase inhibition correlated with the presence of a substituent at the aniline para-position in these compounds. The anticancer effects of lead compound 4-methyl-5-(2-(4- morpholinophenylamino)pyrimidin-4-yl)thiazol-2-amine (18; Ki values of 8.0 and 9.2 nM for aurora A and B, respectively) were shown to emanate from cell death following mitotic failure and increased polyploidy as a consequence of cellular inhibition of aurora A and B kinases. Preliminary in vivo assessment showed that compound 18 was orally bioavailable and possessed anticancer activity. Compound 18 (CYC116) is currently undergoing phase I clinical evaluation in cancer patients.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 507487-90-3